Metabolomic biomarkers in amniotic fluid for early diagnosis of preterm birth and fetal growth restriction
Folia Medica · 2024
DOI: 10.3897/folmed.66.e137403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica, 2024. Verfasst von Charalampos Kolvatzis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Amniotic Fluid, Fetal Growth Retardation, Biomarkers, Premature Birth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preterm birth, affecting about 10% of pregnancies, significantly contributes to perinatal morbidity and mortality. Recent research indicates that metabolomics could enhance pregnancy outcomes and reduce costs by identifying biomarkers related to common pregnancy complications. Our team focused on analyzing amniotic fluid collected during the second trimester to identify potential biomarkers for preterm birth using 1H-NMR metabolomic analysis. We compared amniotic fluid samples from women who delivered prematurely with those who delivered at term. Multivariate principal component analysis revealed dimethylglycine, glucose, myo-inositol, and succinic acid as potential biomarkers for preterm birth prognosis and early diagnosis. Further analysis demonstrated distinct regulation patterns of these metabolites in relation to fetal growth centiles. For instance, dimethylglycine and glucose were upregulated in fetuses above the 20th centile, while citrate and succinate were upregulated in those below it. With Area Under the Curve (AUROC) values over 0.75 and p-values less than 0.05, these metabolites show promise as reliable biomarkers for predicting fetal growth restriction. This approach could significantly impact maternal-fetal medicine by facilitating early diagnosis and personalized interventions. Future research should focus on validating these findings in larger populations and exploring the underlying mechanisms of metabolite regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aristotle University of Thessaloniki, Thessaloniki, Greece.
- University of West Attica, Athens, Greece.
- National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Ioannis Tsakiridis
Zitieren
APA
Kolvatzis, C., Tsiantas, K., Tsakiridis, I., Christodoulou, P., Cheilari, A., Kalogiannidis, I., Zoumpoulakis, P., & Athanasiadis, A. (2024). Metabolomic biomarkers in amniotic fluid for early diagnosis of preterm birth and fetal growth restriction. Folia Medica. https://doi.org/10.3897/folmed.66.e137403
Vancouver
Kolvatzis C, Tsiantas K, Tsakiridis I, Christodoulou P, Cheilari A, Kalogiannidis I, et al. Metabolomic biomarkers in amniotic fluid for early diagnosis of preterm birth and fetal growth restriction. Folia Medica. 2024. doi:10.3897/folmed.66.e137403
BibTeX
@article{Kolvatzis2024,
author = {Kolvatzis, Charalampos and Tsiantas, Konstantinos and Tsakiridis, Ioannis and Christodoulou, Paris and Cheilari, Antigoni and Kalogiannidis, Ioannis and Zoumpoulakis, Panagiotis and Athanasiadis, Apostolos},
title = {Metabolomic biomarkers in amniotic fluid for early diagnosis of preterm birth and fetal growth restriction},
journal = {Folia Medica},
year = {2024},
doi = {10.3897/folmed.66.e137403}
}
EUVIMED